Published in Pediatr Infect Dis on December 20, 1983
Laboratory diagnosis of bacterial meningitis. Clin Microbiol Rev (1992) 2.42
Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis (2005) 2.21
Isolation of Corynebacterium aquaticum from spinal fluid of an infant with meningitis. J Clin Microbiol (1986) 1.19
Corynebacterium aquaticum urinary tract infection in a neonate, and concepts regarding the role of the organism as a neonatal pathogen. J Clin Microbiol (1989) 1.01
Evidence-based guidelines for use of probiotics in preterm neonates. BMC Med (2011) 0.97
Lactobacillus rhamnosus meningitis following recurrent episodes of bacteremia in a child undergoing allogeneic hematopoietic stem cell transplantation. J Clin Microbiol (2010) 0.94
The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by latin-american experts. Paediatr Drugs (2015) 0.78
Lactobacillus Sepsis and Probiotic Therapy in Newborns: Two New Cases and Literature Review. AJP Rep (2015) 0.77
Long-Term Use of Probiotic-Containing Yogurts Is a Safe Way to Prevent Helicobacter pylori: Based on a Mongolian Gerbil's Model. Biochem Res Int (2013) 0.76
Transmission of group B streptococci among parturient women and their neonates. J Pediatr (1973) 6.86
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med (1998) 6.75
Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr (1973) 6.29
Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med (1976) 5.78
Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci. J Immunol (1977) 4.46
Selective broth medium for isolation of group B streptococci. Appl Microbiol (1973) 4.42
Group B streptococcal infections in infants. The importance of the various serotypes. JAMA (1974) 3.71
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr (2000) 3.53
Typing of group B streptococci: comparison of pulsed-field gel electrophoresis and conventional electrophoresis. J Clin Microbiol (1993) 3.52
The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J Exp Med (1980) 3.48
Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol (1982) 3.23
Nontypable Haemophilus influenzae (biotype 4) as a neonatal, maternal, and genital pathogen. Rev Infect Dis (1983) 3.23
Active oxygen in plant pathogenesis. Annu Rev Phytopathol (1995) 3.02
Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics (2001) 2.91
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis (2000) 2.90
Molecular cloning of a Pseudomonas syringae pv. syringae gene cluster that enables Pseudomonas fluorescens to elicit the hypersensitive response in tobacco plants. J Bacteriol (1988) 2.84
Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus. J Exp Med (1976) 2.55
Involvement of plasma membrane calcium influx in bacterial induction of the k/h and hypersensitive responses in tobacco. Plant Physiol (1990) 2.46
Neonatal sepsis caused by a new group B streptococcal serotype. J Pediatr (1993) 2.45
Microcapsule of type III strains of group B Streptococcus: production and morphology. Infect Immun (1976) 2.38
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics (2001) 2.30
Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis (1998) 2.24
Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J Clin Invest (1977) 2.23
Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infect Immun (1978) 2.15
Comparison of bacteriological methods for the isolation of group of B Streptococcus from vaginal cultures. J Clin Microbiol (1976) 2.14
Changing epidemiology of group B streptococcal colonization. Pediatrics (1999) 2.09
Immunodeterminant specificity of human immunity to type III group B streptococcus. J Exp Med (1979) 2.06
Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest (1996) 2.05
The 1997 AAP guidelines for prevention of early-onset group B streptococcal disease. American Academy of Pediatrics. Pediatrics (1997) 2.04
Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children. JAMA (1998) 2.00
Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother (1998) 2.00
Immunogenicity of polysaccharides from type III, group B Streptococcus. J Clin Invest (1978) 1.95
Restriction endonuclease analysis of human and bovine group B streptococci for epidemiologic study. J Clin Microbiol (1989) 1.87
Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics (1981) 1.83
Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis (2000) 1.79
Persistent bacteremia due to coagulase-negative staphylococci in low birth weight neonates. Pediatrics (1989) 1.78
Vaginal colonization with group B streptococcus: a study in college women. J Infect Dis (1977) 1.76
Influenza virus infections in infants. Pediatr Infect Dis J (1997) 1.75
Group B streptococcal vaccines. Rev Infect Dis (1985) 1.74
Group B streptococcal infections. Adv Intern Med (1980) 1.72
Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources. Antimicrob Agents Chemother (1976) 1.72
Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus. J Infect Dis (1979) 1.71
Group B streptococcal cellulitis-adenitis in infants. Am J Dis Child (1982) 1.71
Single oral dose metronidazole therapy for Gardnerella vaginalis vaginitis in adolescent females. J Adolesc Health Care (1983) 1.70
Phenotypic diversity in the alpha C protein of group B streptococci. Infect Immun (1991) 1.64
Congenital ring constrictions and intrauterine amputations. Am J Dis Child (1971) 1.62
Rapid diagnosis of type III group B streptococcal meningitis by latex particle agglutination. J Pediatr (1979) 1.61
Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Neth J Med (2008) 1.57
Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team. N Engl J Med (1997) 1.56
Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis (2008) 1.55
A 5-year review of recurrent group B streptococcal disease: lessons from twin infants. Clin Infect Dis (2000) 1.53
Serum vitamin A levels in respiratory syncytial virus infection. J Pediatr (1994) 1.53
Candida: an increasingly important pathogen in the nursery. Pediatr Clin North Am (1988) 1.53
Twenty years of outpatient respiratory syncytial virus infection: a framework for vaccine efficacy trials. Pediatrics (1997) 1.51
Unusual occurrence of an epidemic of type Ib/c group B streptococcal sepsis in a neonatal intensive care unit. J Infect Dis (1987) 1.51
Long-term sequelae of group B streptococcal meningitis in infants. J Pediatr (1985) 1.49
Commercial latex agglutination for detection of group B streptococcal antigen in body fluids. J Pediatr (1983) 1.47
Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus. J Clin Invest (1982) 1.47
Carriage of group B Streptococci in pregnant Gambian mothers and their infants. J Infect Dis (1994) 1.43
A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatr Res (1987) 1.42
Infections due to Mycoplasma pneumoniae in childhood. Pediatr Infect Dis (1986) 1.42
Quantitative determination of antibodies to type III group B streptococcal polysaccharide. J Infect Dis (1996) 1.41
Immune response of infants and children to disseminated infections with Neisseria meningitidis. J Infect Dis (1984) 1.41
Identification of sialic acid in polysaccharide antigens in group B Streptococcus. Infect Immun (1976) 1.38
Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. Vaccine (1999) 1.37
Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol (2000) 1.36
Variations in HIV risk behaviors of incarcerated juveniles during a four-year period: 1989-1992. J Adolesc Health (1998) 1.36
Discitis and vertebral osteomyelitis in children: an 18-year review. Pediatrics (2000) 1.35
Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. J Infect Dis (2001) 1.33
Methylobacterium mesophilica as a cause of persistent bacteremia in a child with lymphoma. Pediatr Infect Dis J (1997) 1.33
Moxalactam therapy for neonatal meningitis due to gram-negative enteric bacilli. A prospective controlled evaluation. JAMA (1984) 1.31
Luminol-enhanced chemiluminescence for evaluation of type III group B streptococcal opsonins in human sera. J Infect Dis (1980) 1.27
Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children. Philos Trans R Soc Lond B Biol Sci (2001) 1.26
Transient Activation of Plasmalemma K Efflux and H Influx in Tobacco by a Pectate Lyase Isozyme from Erwinia chrysanthemi. Plant Physiol (1986) 1.26
Electron microscopic definition of surface antigens of group B Streptococcus. J Infect Dis (1979) 1.25
Sialylation and human neutrophil killing of group C Neisseria meningitidis. J Infect Dis (1992) 1.24
Invasive group B streptococcal disease in children beyond early infancy. Pediatr Infect Dis J (1995) 1.24
Role of complement receptors in opsonophagocytosis of group B streptococci by adult and neonatal neutrophils. J Infect Dis (1990) 1.24
Candidal meningitis in neonates: a 10-year review. Clin Infect Dis (2000) 1.24
Complications and sequelae of meningococcal infections in children. J Pediatr (1981) 1.23
Prospective diagnosis of early onset group B streptococcal infection by countercurrent immunoelectrophoresis. J Pediatr (1979) 1.22
Antibody to group B Streptococcus type III in human sera measured by a mouse protection test. Infect Immun (1981) 1.22
Role of the Plasmalemma H-ATPase in Pseudomonas syringae-Induced K/H Exchange in Suspension-Cultured Tobacco Cells. Plant Physiol (1989) 1.21
Comparison of slide coagglutination test and countercurrent immunoelectrophoresis for detection of group B streptococcal antigen in cerebrospinal fluid from infants with meningitis. J Clin Microbiol (1980) 1.19
Commercial latex agglutination test for rapid diagnosis of group B streptococcal infection in infants. J Clin Microbiol (1980) 1.19
Immunochemical characterization of native polysaccharides from group B streptococcus: the relationship of the type III and group B determinants. J Immunol (1978) 1.18
Neonatal meningitis. Arch Dis Child Fetal Neonatal Ed (2003) 1.18
Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatr Infect Dis J (2000) 1.17
Potentiation of virulence by group B streptococcal polysaccharides. J Infect Dis (1984) 1.17
Group B streptococcal infection in newborns: prevention at last? N Engl J Med (1986) 1.16
An etiologic shift in infantile osteomyelitis: the emergence of the group B streptococcus. J Pediatr (1978) 1.15
Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide. J Clin Invest (1983) 1.15
Deposition and degradation of C3 on type III group B streptococci. Infect Immun (1991) 1.15
Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia. Clin Infect Dis (2001) 1.15
Contributions of complement and immunoglobulin to neutrophil-mediated killing of enterococci. Infect Immun (1992) 1.14
Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus. J Infect Dis (1977) 1.13
The natural history of group B streptococcal colonization in the pregnant woman and her offspring. II. Determination of serum antibody to capsular polysaccharide from type III, group B Streptococcus. Am J Obstet Gynecol (1980) 1.11